Skip to main content
. Author manuscript; available in PMC: 2019 Dec 3.
Published in final edited form as: Acta Anaesthesiol Scand. 2009 Mar;53(3):354–363. doi: 10.1111/j.1399-6576.2008.01874.x

Table 3.

Association between potential predictive factors and occurrence of pain during BMA

Variable Observation (n) Pain during BMA rate, % OR (95% CI) P-value
Age*
 <60 years 108 76.8 1.82 (1.02–3.24) 0.041
 ≥ 60 years 127 64.5
Sex*
 Female 109 76.2 1.71 (0.97–3.04) 0.064
 Male 126 65.1
Prior BMA*
 Yes 100 75.6 1.82 (1.03–3.19) 0.038
 No 135 63
Pre-existing pain*
 Yes 101 78.2 2.05 (1.14–3.71) 0.017
 No 132 63.6
Pain before BMA*
 Yes 69 82.6 2.60 (1.29–5.23) 0.007
 No 164 64.6
Anxiety about needle-insertion*
 Yes 126 82.5 3.72 (2.05–6.75) <0.001
 No 109 56
Anxiety about BMA result*
 Yes 147 80.2 3.55 (1.98–6.36) <0.001
 No 88 53.4
Received written information
 No 143 70.6 1.03 (0.58–1.84) 0.918
 Yes 90 70
Received oral information
 No 24 70.8 1.02 (0.4–2.57) 0.976
 Yes 207 70.5
Pain medication taken same day as BMA
 Yes 44 75 1.34 (0.63–2.83) 0.446
 No 188 69.2
Body mass index
 ≥ 25 91 71.4 1.08 (0.60–1.94) 0.799
 <25 136 69.8
BMA duration
 ≥ 15 min 50 78 1.66 (0.79–3.48) 0.179
 < 15 min 182 68
Experience of physician
 ≤ 100 BMA 50 66 0.78 (0.40–1.52) 0.464
 >100 BMA 185 71.3
Education of physician
 Hematology fellow 174 68.3 0.71 (0.36–1.37) 0.303
 Attending hematologist 61 75.4
Type of BMA
 Both aspiration and biopsy 80 76.2 1.75 (0.89–3.43) 0.106
 Bone marrow aspiration 67 70.1 1.28 (0.65–2.53) 0.481
 Bone marrow biopsy 88 64.8
Economical situation
 Bad 20 75 1.36 (0.47–3.93) 0.574
 Either bad or good 44 72.7 1.21 (0.58–2.53) 0.260
 Good 167 68.9
Marital status
 Single 46 78.3 2.31 (0.78–6.90) 0.132
 Divorced/separated 12 75 1.93 (0.41–9.10) 0.407
 Married/cohabiting 147 70.1 1.50 (0.61–3.73) 0.378
 Widow/widower 23 60.9
Foreign background
 Yes 59 74.6 1.34 (0.69–2.62) 0.388
 No 172 68.6
Employment status
 Sick-leave or unemployed 79 83.5 2.96 (1.45–6.03) 0.003
 Working or studying 50 64.0 1.04 (0.51–2.08) 0.924
 Retired 106 63.2
Education level*
 High 85 78.8 2.36 (1.09–5.12) 0.030
 Intermediate 95 68.4 1.37 (0.67–2.82) 0.389
 Low§ 49 61.2
Underlying diagnosis
 Multiple myeloma 39 76.9 1.59 (0.57–4.49) 0.377
 Lymphoma 46 69.6 1.09 (0.42–2.84) 0.855
 Myelodysplastic syndrome 18 66.7 0.96 (0.28–3.22) 0.943
 Chronic myeloproliferative disorder 31 71.0 1.17 (0.41–3.36) 0.772
 Other hematologic disease 42 69.0 1.07 (0.40–2.82) 0.897
 Non-hematologic disease 25 68.0 1.02 (0.34–3.07) 0.977
 Leukemia 34 67.6
Platelet count (109/l) 1.00 (0.99–1.00) 0.795
Hemoglobin level (g/l) 1.00 (0.99–1.01) 0.671
Total STAI S 10*,, 1.59 (1.22–2.05) <0.001
Total STAI T 10*,,** 1.97 (1.29–3.01) 0.002

The last category of each nominal variable was used as the reference category.

*

Variables selected for multivariate model.

University/similar.

Upper secondary school/similar.

§

Primary school/similar or lower.

Ten units increments.

Internal attrition; n = 13.

**

Internal attrition; n = 19.

BMA, bone marrow aspiration/biopsy.